Evguenia M. Alexandrova

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer”.

The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

Cell Death and Disease(2021)10.1038/s41419-021-03414-3

N/A

0DataRank · unranked

10 citations

John D. Haley, Evguenia M. Alexandrova, Christopher Eyermann

p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer

Cell Death and Disease(2021)10.1038/s41419-021-03795-5

N/A

0DataRank · unranked

6 citations

Jinyu Li, Evguenia M. Alexandrova, Christopher Eyermann

ΔNp63 Regulates Homeostasis, Stemness, and Suppression of Inflammation in the Adult Epidermis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.17.504172

N/A

0DataRank · unranked

0 citations

Xi Chen, Ozge Somuncu, Jinyu Li, Alexander N. Joukov, Jiang Chen +2 more

ΔNp63 Regulates Homeostasis, Stemness, and Suppression of Inflammation in the Adult Epidermis

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.07.005

N/A

0DataRank · unranked

15 citations

Xi Chen, Ozge Somuncu, Jinyu Li, Alexander N. Joukov, Jiang Chen +2 more

Biliverdin reductase B as a new target in breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-02147-x

N/A

0DataRank · unranked

0 citations

Natasha M. Nesbitt, Evguenia M. Alexandrova, Julie A. Reisz, Angelo D’Alessandro, Joonhyuk Suh +4 more